InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,850.40
(
0.02%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
85.63
(
-1.02%
)
Bitcoin
57,180.30
(
2.39%
)
Post# of 252506
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 67576

Tuesday, 01/26/2010 3:25:11 AM

Tuesday, January 26, 2010 3:25:11 AM

Post# of 252506
NVS announces senior management transition: Dan Vasella, who has been CEO since the company’s formation in 1996 (the longest reign of any current Big Pharma CEO) is handing the reins to Joe Jimenez, who had been chief of NVS’ pharma division. Vasella will remain Chairman of the Board. The new head of NVS’ pharma division will be David Epstein, who had been head of oncology.

This announcement was made in conjunction with NVS’ 4Q09 financial results.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up